Analysis of the BCR-ABL protein in Philadelphia chromosome positive adult acute lymphocytic leukemia (ALL) by enhanced chemiluminiscence western blotting (Eq-WB).

被引：0

作者：

Bseiso, AW

Kantarjian, HM

Guo, JQ

Talpaz, M

OBrien, S

Koller, C

Albitar, M

Keating, M

Arlinghaus, R

机构：

[1] UNIV TEXAS,MD ANDERSON CANCER CTR,SECT HEMATOL,HOUSTON,TX 77030

[2] UNIV TEXAS,MD ANDERSON CANCER CTR,SECT MOL PATHOL,HOUSTON,TX 77030

[3] UNIV TEXAS,MD ANDERSON CANCER CTR,SECT BIOIMMUNOTHERAPY,HOUSTON,TX 77030

[4] UNIV TEXAS,MD ANDERSON CANCER CTR,LAB MED,HOUSTON,TX 77030

来源：

BLOOD | 1996年 / 88卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：3335 / 3335

页数：1

共 50 条

[31] A novel maxizyme vector targeting a bcr-abl fusion gene induced specific cell death in Philadelphia chromosome-positive acute lymphoblastic leukemia
Soda, Y
Tani, K
Bal, Y
Saiki, M
Chen, M
Izawa, K
Kobayashi, S
Takahashi, S
Uchimaru, K
Kuwabara, T
Warashina, M
Tanabe, T
Miyoshi, H
Sugita, K
Nakazawa, S
Tojo, A
Taira, K
Asano, S
BLOOD, 2004, 104 (02) : 356 - 363
[32] REARRANGEMENT OF THE BREAKPOINT CLUSTER REGION AND EXPRESSION OF P210 BCR-ABL IN A MASKED PHILADELPHIA CHROMOSOME-POSITIVE ACUTE MYELOID-LEUKEMIA
PRICE, CM
RASSOOL, F
SHIVJI, MKK
GOW, J
TEW, CJ
HAWORTH, C
GOLDMAN, JM
WIEDEMANN, LM
BLOOD, 1988, 72 (05) : 1829 - 1832
[33] Multi-Lineage BCR-ABL Expression in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Is Associated With Improved Prognosis but No Specific Molecular Features
Nishiwaki, Satoshi
Kim, Jeong Hui
Ito, Masafumi
Maeda, Matsuyoshi
Okuno, Yusuke
Koyama, Daisuke
Ozawa, Yukiyasu
Gunji, Masaharu
Osaki, Masahide
Kitamura, Kunio
Ushijima, Yoko
Ishikawa, Yuichi
Miyamura, Koichi
Sugiura, Isamu
Kiyoi, Hitoshi
FRONTIERS IN ONCOLOGY, 2020, 10
[34] CLOSELY RELATED BCR/ABL ONCOGENES ARE ASSOCIATED WITH THE DISTINCTIVE CLINICAL BIOLOGIES OF PHILADELPHIA-CHROMOSOME POSITIVE CHRONIC MYELOGENOUS AND ACUTE LYMPHOCYTIC-LEUKEMIA
WITTE, ON
CURRENT TOPICS IN MICROBIOLOGY AND IMMUNOLOGY, 1988, 141 : 42 - 49
[35] VARIANT BCR-ABL1 FUSION GENES IN ADULT PHILADELPHIA CHROMOSOME-POSITIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Langabeer, Stephen E.
EXCLI JOURNAL, 2017, 16
[36] The synthetic hest shock protein (Hsp) 90 inhibitor EC141 induces degradation of the Bcr-Abl p190 protein and apoptosis of Philadelphia chromosome (Ph)-positive acute lymphoblastic Leukemia (ALL) cells
Ferrajoli, Alessandra
Wang, Yongtao
O'Brien, Susan M.
Faderl, Stefan H.
Harris, David M.
Van, Quin
Hallevi, Inbal
Liu, Zhiming
Koch, Patricia E.
Sensintaffar, John
Burrows, Francis
Kantarjian, Hagop M.
Keating, Michael J.
Estrov, Zeev
BLOOD, 2007, 110 (11) : 819A - 819A
[37] Minimal residual disease (MRD) analysis of BCR-ABL positive acute lymphocytic leukemia (ALL) patients during STI571 kinase inhibitor therapy.
Scheuring, UJ
Wassmann, B
Pfeiffer, H
Capdeville, R
Petershofen, E
Gschaidmeier, H
Hoelzer, D
Ottmann, OG
BLOOD, 2000, 96 (11) : 465A - 465A
[38] CHIMERIC BCR-ABL MESSENGER-RNA AS A MARKER FOR MINIMAL RESIDUAL DISEASE IN PATIENTS TRANSPLANTED FOR PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA
GEHLY, GB
BRYANT, EM
LEE, AM
KIDD, PG
THOMAS, ED
BLOOD, 1991, 78 (02) : 458 - 465
[39] Leptomycin B overcomes imatinib resistance mediated by stromal cells and mutant BCR-ABL in Philadelphia chromosome-positive acute lymphoblastic leukemia cells.
Tojo, A
Izawa, K
Sekine, R
Nagamura, T
Yoshida, M
Tsuji, T
BLOOD, 2004, 104 (11) : 575A - 575A
[40] Inhibition of growth of a Philadelphia-chromosome positive acute lymphoblastic leukemia cell line by antisense oligonucleotides specific for the p190 bcr-abl oncogene
Snyder, DS
Wu, Y
McMahon, R
Forman, SJ
BLOOD, 1995, 86 (10) : 2956 - 2956

← 1 2 3 4 5 →